AUPH logo

Aurinia Pharmaceuticals (AUPH) Accounts payable

annual accounts payable:

$5.19M+$860.00K(+19.88%)
December 31, 2024

Summary

  • As of today (May 25, 2025), AUPH annual accounts payable is $5.19 million, with the most recent change of +$860.00 thousand (+19.88%) on December 31, 2024.
  • During the last 3 years, AUPH annual accounts payable has risen by +$1.31 million (+33.72%).
  • AUPH annual accounts payable is now at all-time high.

Performance

AUPH Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHbalance sheet metrics

quarterly accounts payable:

$4.22M-$967.00K(-18.64%)
March 31, 2025

Summary

  • As of today (May 25, 2025), AUPH quarterly accounts payable is $4.22 million, with the most recent change of -$967.00 thousand (-18.64%) on March 31, 2025.
  • Over the past year, AUPH quarterly accounts payable has dropped by -$1.45 million (-25.60%).
  • AUPH quarterly accounts payable is now -52.47% below its all-time high of $8.88 million, reached on September 30, 2024.

Performance

AUPH quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAUPHbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

AUPH Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+19.9%-25.6%
3 y3 years+33.7%+29.2%
5 y5 years+24.9%-

AUPH Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+68.0%-52.5%+36.7%
5 y5-yearat high+96.8%-52.5%+93.4%
alltimeall timeat high+1279.2%-52.5%+1022.0%

AUPH Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$4.22M(-18.6%)
Dec 2024
$5.19M(+19.9%)
$5.19M(-41.6%)
Sep 2024
-
$8.88M(+5.5%)
Jun 2024
-
$8.41M(+48.4%)
Mar 2024
-
$5.67M(+31.1%)
Dec 2023
$4.33M(+40.2%)
$4.33M(-51.1%)
Sep 2023
-
$8.85M(+84.2%)
Jun 2023
-
$4.81M(+30.7%)
Mar 2023
-
$3.68M(+19.2%)
Dec 2022
$3.09M(-20.4%)
$3.09M(-5.5%)
Mar 2022
-
$3.27M(-15.8%)
Dec 2021
$3.88M(+47.2%)
$3.88M(+18.9%)
Sep 2021
-
$3.26M(+28.7%)
Jun 2021
-
$2.54M(+16.2%)
Mar 2021
-
$2.18M(-17.2%)
Dec 2020
$2.63M(-36.6%)
$2.63M(-36.6%)
Dec 2019
$4.15M(+40.7%)
$4.15M(+40.7%)
Dec 2018
$2.95M(-21.8%)
$2.95M(-21.8%)
Dec 2017
$3.77M(+31.8%)
$3.77M(+31.8%)
Dec 2016
$2.86M(+37.7%)
$2.86M(+37.7%)
Dec 2015
$2.08M(+49.4%)
$2.08M(+49.4%)
Dec 2014
$1.39M(+26.0%)
$1.39M(+26.0%)
Dec 2013
$1.10M(-5.2%)
$1.10M(+3.1%)
Sep 2013
-
$1.07M(-57.3%)
Jun 2013
-
$2.51M(+21.3%)
Mar 2013
-
$2.07M(+77.7%)
Dec 2012
$1.17M(+209.8%)
$1.17M(-60.6%)
Sep 2012
-
$2.95M(+685.6%)
Dec 2011
$376.10K
$376.10K(-89.5%)
Sep 2008
-
$3.59M(-23.6%)
Jun 2008
-
$4.69M(+18.3%)
Mar 2008
-
$3.97M(-36.9%)
Sep 2007
-
$6.29M(-16.9%)
Jun 2007
-
$7.57M(+53.5%)
DateAnnualQuarterly
Mar 2007
-
$4.93M(+50.7%)
Dec 2006
$3.27M(-32.7%)
$3.27M(-21.5%)
Sep 2006
-
$4.17M(+36.1%)
Jun 2006
-
$3.06M(-28.7%)
Mar 2006
-
$4.30M(-11.6%)
Dec 2005
$4.86M(+28.4%)
$4.86M(+48.1%)
Sep 2005
-
$3.28M(+26.3%)
Jun 2005
-
$2.60M(+7.7%)
Mar 2005
-
$2.41M(-36.2%)
Dec 2004
$3.79M(-25.8%)
$3.79M(+12.3%)
Sep 2004
-
$3.37M(+31.6%)
Jun 2004
-
$2.56M(-47.4%)
Mar 2004
-
$4.87M(-4.6%)
Dec 2003
$5.10M(+129.8%)
$5.10M(+43.6%)
Sep 2003
-
$3.55M(+9.4%)
Jun 2003
-
$3.25M(+18.1%)
Mar 2003
-
$2.75M(+23.8%)
Dec 2002
$2.22M(+34.5%)
$2.22M(-21.9%)
Sep 2002
-
$2.84M(-26.9%)
Jun 2002
-
$3.89M(+144.1%)
Mar 2002
-
$1.59M(-59.9%)
Dec 2001
$1.65M(+49.7%)
-
Aug 2001
-
$3.97M(+280.8%)
May 2001
-
$1.04M(+31.9%)
Feb 2001
-
$790.70K(-28.3%)
Nov 2000
$1.10M(+47.7%)
$1.10M(+72.5%)
Aug 2000
-
$639.60K(-12.9%)
May 2000
-
$734.10K(+33.2%)
Feb 2000
-
$551.30K(-26.2%)
Nov 1999
$747.00K(-36.3%)
$747.00K(+1.5%)
Aug 1999
-
$736.00K(-9.6%)
May 1999
-
$813.80K(-18.2%)
Feb 1999
-
$994.40K
Nov 1998
$1.17M
-

FAQ

  • What is Aurinia Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals annual accounts payable year-on-year change?
  • What is Aurinia Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals quarterly accounts payable year-on-year change?

What is Aurinia Pharmaceuticals annual accounts payable?

The current annual accounts payable of AUPH is $5.19M

What is the all time high annual accounts payable for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high annual accounts payable is $5.19M

What is Aurinia Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, AUPH annual accounts payable has changed by +$860.00K (+19.88%)

What is Aurinia Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of AUPH is $4.22M

What is the all time high quarterly accounts payable for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high quarterly accounts payable is $8.88M

What is Aurinia Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, AUPH quarterly accounts payable has changed by -$1.45M (-25.60%)
On this page